Works matching IS 0344-5704 AND VI 66 AND IP 5 AND DT 2010

Results: 25

Se-methylselenocysteine sensitizes hypoxic tumor cells to irinotecan by targeting hypoxia-inducible factor 1alpha.

Published in:

2010

By:

Chintala S;
Tóth K;
Cao S;
Durrani FA;
Vaughan MM;
Jensen RL;
Rustum YM;
Chintala, Sreenivasulu;
Tóth, Károly;
Cao, Shousong;
Durrani, Farukh A;
Vaughan, Mary M;
Jensen, Randy L;
Rustum, Youcef M

Publication type:

journal article

Voreloxin, a first-in-class anticancer quinolone derivative, acts synergistically with cytarabine in vitro and induces bone marrow aplasia in vivo.

Published in:

2010

By:

Scatena CD;
Kumer JL;
Arbitrario JP;
Howlett AR;
Hawtin RE;
Fox JA;
Silverman JA;
Scatena, Caroline D;
Kumer, Jeffrey L;
Arbitrario, Jennifer P;
Howlett, Anthony R;
Hawtin, Rachael E;
Fox, Judith A;
Silverman, Jeffrey A

Publication type:

journal article

Plasma and cerebrospinal fluid pharmacokinetics of topotecan in a phase I trial of topotecan, tamoxifen, and carboplatin, in the treatment of recurrent or refractory brain or spinal cord tumors.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 5, p. 927, doi. 10.1007/s00280-010-1242-z

By:

Morgan, Robert J.;
Synold, Timothy;
Mamelak, Adam;
Lim, Dean;
Al-Kadhimi, Zaid;
Twardowski, Przemyslaw;
Leong, Lucille;
Chow, Warren;
Margolin, Kim;
Shibata, Stephen;
Somlo, George;
Yen, Yun;
Frankel, Paul;
Doroshow, James H.

Publication type:

Article

Phase II study with fractionated schedule of docetaxel and cisplatin in patients with advanced non-small cell lung cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 5, p. 889, doi. 10.1007/s00280-009-1235-y

By:

Jung Hye Kwon;
Jung Han Kim;
Jung-Ae Lee;
Hyun Chun Shin;
Hyo Jung Kim;
Hun Ho Song;
Joo Young Jung;
Ho Young Kim;
Dae Ro Choi;
Hyeong Su Kim;
Young-iee Park;
Dae Young Zang

Publication type:

Article

Se-methylselenocysteine sensitizes hypoxic tumor cells to irinotecan by targeting hypoxia-inducible factor 1α.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 5, p. 899, doi. 10.1007/s00280-009-1238-8

By:

Chintala, Sreenivasulu;
Tóth, Károly;
Cao, Shousong;
Durrani, Farukh A.;
Vaughan, Mary M.;
Jensen, Randy L.;
Rustum, Youcef M.

Publication type:

Article

Phase II study of S-1 and docetaxel for previously treated patients with locally advanced or metastatic non-small cell lung cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 5, p. 913, doi. 10.1007/s00280-009-1239-7

By:

Yanagihara, Kazuhiro;
Yoshimura, Kenichi;
Niimi, Miyuki;
Yasuda, Hiroyasu;
Sasaki, Takahiko;
Nishimura, Takafumi;
Ishiguro, Hiroshi;
Matsumoto, Shigemi;
Kitano, Toshiyuki;
Kanai, Masashi;
Misawa, Akiko;
Tada, Harue;
Teramukai, Satoshi;
Mio, Tadashi;
Fukushima, Masanori

Publication type:

Article

A phase II study of fenretinide in patients with hormone refractory prostate cancer: a trial of the Cancer Therapeutics Research Group.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 5, p. 845, doi. 10.1007/s00280-009-1228-x

By:

Moore, M. M.;
Stockler, M.;
Lim, R.;
Mok, T. S. K.;
Millward, M.;
Boyer, M. J.

Publication type:

Article

A general process for the development of peptide-based immunoassays for monoclonal antibodies.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 5, p. 919, doi. 10.1007/s00280-009-1240-1

By:

Sanchez, Ana B.;
Nguyen, Tammy;
Dema-Ala, Rhanika;
Kummel, Andrew C.;
Kipps, Thomas J.;
Messmer, Bradley T.

Publication type:

Article

Relationship among pharmacokinetics and pharmacodynamics of fenretinide and plasma retinol reduction in neuroblastoma patients.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 5, p. 993, doi. 10.1007/s00280-010-1370-5

By:

Formelli, Franca;
Cavadini, Elena;
Luksch, Roberto;
Garaventa, Alberto;
Appierto, Valentina;
Persiani, Stefano

Publication type:

Article

The Bcl-2 inhibitor ABT-263 enhances the response of multiple chemotherapeutic regimens in hematologic tumors in vivo.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 5, p. 869, doi. 10.1007/s00280-009-1232-1

By:

Ackler, Scott;
Mitten, Michael J.;
Foster, Kelly;
Oleksijew, Anatol;
Refici, Marion;
Tahir, Stephen K.;
Yu Xiao;
Tse, Christin;
Frost, David J.;
Fesik, Stephen W.;
Rosenberg, Saul H.;
Elmore, Steven W.;
Shoemaker, Alexander R.

Publication type:

Article

Enhancement of cisplatin sensitivity by NSC109268 in budding yeast and human cancer cells is associated with inhibition of S-phase progression.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 5, p. 945, doi. 10.1007/s00280-010-1246-8

By:

Jain, Dilip;
Patel, Nila;
Shelton, Melanie;
Basu, Alakananda;
Roque, Rouel;
Siede, Wolfram

Publication type:

Article

Phase 1 study of the investigational, oral angiogenesis inhibitor motesanib in Japanese patients with advanced solid tumors.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 5, p. 935, doi. 10.1007/s00280-010-1243-y

By:

Fujisaka, Yasuhito;
Yamada, Yasuhide;
Yamamoto, Noboru;
Shimizu, Toshio;
Fujiwara, Yutaka;
Yamada, Kazuhiko;
Tamura, Tomohide;
Watanabe, Hiroyuki;
Yu-Nien Sun;
Bass, Michael B.;
Seki, Mitsuo

Publication type:

Article

Increased anticoagulant activity of warfarin used in combination with doxifluridine.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 5, p. 969, doi. 10.1007/s00280-010-1249-5

By:

Nakajima, Masaru;
Genda, Tomoo;
Suehira, Mayu;
Satoh, Hiroki;
Miki, Akiko;
Hori, Satoko;
Sawada, Yasufumi

Publication type:

Article

Voreloxin, a first-in-class anticancer quinolone derivative, acts synergistically with cytarabine in vitro and induces bone marrow aplasia in vivo.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 5, p. 881, doi. 10.1007/s00280-009-1234-z

By:

Scatena, Caroline D.;
Kumer, Jeffrey L.;
Arbitrario, Jennifer P.;
Howlett, Anthony R.;
Hawtin, Rachael E.;
Fox, Judith A.;
Silverman, Jeffrey A.

Publication type:

Article

Syl611, a novel semisynthetic taxane derivative, reverses multidrug resistance by p-glycoprotein inhibition and facilitating inward transmembrane action.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 5, p. 851, doi. 10.1007/s00280-009-1229-9

By:

Yi Zhang;
Hongyan Li;
Hongbo Wang;
Fuqin Su;
Runjiang Qu;
Dali Yin;
Jungui Dai;
Yan Li;
Xiaoguang Chen

Publication type:

Article

A phase-I trial of pemetrexed plus carboplatin in recurrent ovarian cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 5, p. 861, doi. 10.1007/s00280-009-1230-3

By:

Sehouli, Jalid;
Camara, Oumar;
Mahner, Sven;
Bauknecht, Thomas;
Lichtenegger, Werner;
Runnebaum, Ingo;
Look, Katherine;
Jaenicke, Fritz;
Oskay-Oezcelik, Guelten

Publication type:

Article

The maximum tolerated dose and biologic effects of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) in combination with irinotecan for patients with refractory solid tumors.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 5, p. 973, doi. 10.1007/s00280-010-1250-z

By:

Choi, Brian S.;
Alberti, Dona B.;
Schelman, William R.;
Kolesar, Jill M.;
Thomas, James P.;
Marnocha, Rebecca;
Eickhoff, Jens C.;
Ivy, S. Percy;
Wilding, George;
Holen, Kyle D.

Publication type:

Article

Phase II study of pemetrexed in patients with advanced neuroendocrine tumors.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 5, p. 961, doi. 10.1007/s00280-010-1248-6

By:

Chan, Jennifer A.;
Zhu, Andrew X.;
Stuart, Keith;
Bhargava, Pankaj;
Earle, Craig C.;
Clark, Jeffrey W.;
Casey, Carolyn;
Regan, Eileen;
Kulke, Matthew H.

Publication type:

Article

A phase II study of combination therapy with irinotecan and S-1 (IRIS) in patients with advanced colorectal cancer.

Published in:

2010

By:

Shiozawa, Manabu;
Akaike, Makoto;
Sugano, Nobuhiro;
Tsuchida, Kazuhito;
Yamamoto, Naoto;
Morinaga, Soichiro

Publication type:

Report

Down-regulation of lipids transporter ABCA1 increases the cytotoxicity of Nitidine.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 5, p. 953, doi. 10.1007/s00280-010-1247-7

By:

Iwasaki, Hironori;
Okabe, Takafumi;
Takara, Kensaku;
Yoshida, Yasuhiko;
Hanashiro, Kaoru;
Oku, Hirosuke

Publication type:

Article

Antitumor effects of recombinant human Interleukin-6 on mouse bladder carcinoma through Fas-mediated apoptosis.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 5, p. 981, doi. 10.1007/s00280-010-1336-7

By:

Chuan-gang Li;
Mo-lin Li;
Xiao-hong Shu;
Yong-ji Liu;
Wen-sen Wu

Publication type:

Article

C6 ceramide potentiates curcumin-induced cell death and apoptosis in melanoma cell lines in vitro.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 5, p. 999, doi. 10.1007/s00280-010-1374-1

By:

Teng Yu;
Jinchao Li;
Hui Sun

Publication type:

Article

A phase I trial of lomeguatrib and irinotecan in metastatic colorectal cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 5, p. 829, doi. 10.1007/s00280-009-1225-0

By:

Sabharwal, A.;
Corrie, P. G.;
Midgley, R. S.;
Palmer, C.;
Brady, J.;
Mortimer, P.;
Watson, A. J.;
Margison, G. P.;
Middleton, M. R.

Publication type:

Article

Efficacy of CR3294, a new benzamidine derivative, in the prevention of 5-fluorouracil-induced gastrointestinal mucositis and diarrhea in mice.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 5, p. 819, doi. 10.1007/s00280-009-1224-1

By:

Letari, Ornella;
Booth, Catherine;
Bonazzi, Albino;
Garofalo, Paolo;
Makovec, Francesco;
Rovati, Lucio C.;
Caselli, Gianfranco

Publication type:

Article

Sorafenib plus octreotide is an effective and safe treatment in advanced hepatocellular carcinoma: multicenter phase II So.LAR. study.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 5, p. 837, doi. 10.1007/s00280-009-1226-z

By:

Del Prete, Salvatore;
Montella, Liliana;
Caraglia, Michele;
Maiorino, Luigi;
Cennamo, Gregorio;
Montesarchio, Vincenzo;
Piai, Guido;
Febbraro, Antonio;
Tarantino, Luciano;
Capasso, Elena;
Palmieri, Giovannella;
Guarrasi, Rosario;
Bianco, Maddalena;
Mamone, Rosanna;
Savastano, Clementina;
Pisano, Agata;
Vincenzi, Bruno;
Sabia, Antonietta;
D'Agostino, Alberto;
Faiola, Vincenzo

Publication type:

Article